• Welcome Message
  • Board of Trustees

ICRF President’s Letter

Dear Friends:

Thank you for your interest in – and support of – the Israel Cancer Research Fund (ICRF).  We are North America’s largest non-profit dedicated to funding Israeli cancer research.

I am happy to report that the rate of discovery in cancer research is accelerating – and nowhere more than in Israel. Israel is a major source of innovation in the understanding and treatment of cancer. Many of Israel’s most promising cancer research investigations have been funded by ICRF.

As a result of our careful proposal review process, we have provided funding that has helped to propel the careers of some of the world’s leading cancer researchers, including Professor Howard Cedar and Nobel Prize winning scientists Drs. Avram Hershko and Aaron Ciechanover, to name just a few.

Looking to the future, we are particularly excited by our partnership with the City of Hope in Los Angeles, which supports high-potential research collaborations while promoting the exchange of ideas and information between exceptional cancer researchers in the U.S. and Israel.

To me, the case for support of ICRF is clear-cut and compelling. Israeli cancer research is world-class and, due to lower overhead costs and ICRF’s ability to directly fund its grantees, cost-effective. Or as my financial services friends might put it, with ICRF you get both growth and value.

A prominent Israeli cancer researcher was once asked, “When will there be a cure for cancer?” His response: “No money, never. Some money, one day. More money, sooner.”

But know, too, that even as we push smartly and energetically forward towards cures, we are making important advances that are benefitting millions of families now. From Velcade® to Doxil® to Gleevec®, ICRF scientists have made essential contributions to the development of many groundbreaking drugs, giving millions of families, including mine, the greatest gift of all – more time together.

Unfortunately, every year, ICRF receives more promising research proposals than we have dollars to fund. Our goal: to make sure that no deserving cancer research project in Israel goes unfunded. Ever. With your help, we can make that happen.


Rob Densen
President, ICRF International

International Chair’s Letter

Dear Friends:

ICRF was founded 45 years ago by a group of American physicians and scientists to provide funding for cancer research in Israel. Our mission is to further advance our understanding of cancer and facilitate discoveries that might lead to effective treatments. While the initial focus of our founders was to prevent the “brain drain” of talented and brilliant Israeli researchers leaving the country due to lack of financial support, their ultimate dream is still our dream today – that a cure for cancer will be discovered in Israel – and benefit all humankind.

To date, ICRF has transferred over $72 million, which has funded nearly 2,500 grants conducted by Israeli scientists at 22 different Israeli research labs. This accomplishment is a credit to the successful combination of generous donors, outstanding scientists, enthusiastic volunteers, and devoted staff – all are essential to the achievement of our mission.

Cancer scientists in Israel are invited to submit their grant proposals to ICRF which are then rigorously reviewed and graded by a scientific review board to ensure that the best and most promising grant proposals are identified. Each year, renowned scientists and highly esteemed oncologists gather in New York to review these scientific grant applications from Israeli scientists. And each year, there are more superb grant proposals worthy of funding than dollars available to support them.

And so our challenge is to raise as much money as possible through our chapters (6 in the U.S., 2 in Canada and 1 in Israel) to support the groundbreaking work of Israeli cancer scientists. By doing so we accomplish two worthy goals – first, contributing to top notch research aimed at discovering the keys to combating cancer and developing effective cures, and second, supporting Israel by helping to fund its best scientists.

Over the past decade, I had the privilege of participating in three scientific missions to Israel with ICRF supporters. At research labs across Israel we heard first hand from Israeli scientists about the advances they were making and the pressing need for more funds to support their research. These missions strengthened my personal connection to ICRF and inspired me to help elevate our brand and increase awareness of and support for the invaluable work done by cancer scientists in Israel.

I am proud and honored to serve as Chair of ICRF International. I hope to build on the achievements of my predecessors with the goal of funding as many outstanding Israeli scientists as possible in their quest to increase cancer understanding leading to effective treatments.

Thanks to those of you who have contributed to ICRF – you can be proud that you have become a valuable stakeholder in working towards a cure for cancer. For those who are new to ICRF, we look forward to engaging with you on our journey to support cancer research in Israel.


Bryna Goldberg
Chair, ICRF International

  • Upcoming Events
  • Past Events
  • ICRF International Board of Trustees

  • President

    Rob Densen

  • Chair

    Bryna Goldberg

  • First Vice-President

    Joel Pelofsky

  • Vice-Chairman

    Peter J. Stambrook, PhD

  • Vice Presidents

    David Abramson
    Charles Ben Dayan
    Jeffrey Bernstein

  • Treasurer

    Alan Berk

  • Secretary

    Cynthia Perl

  • Executive Committee Members

    Arnold Baskies, MD
    Benjamin Bonavida, PhD
    Vera Finkelstein
    Brad Goldhar
    Yashar Hirshaut, MD

  • Trustees

    Robert Bard
    Bruce Barron
    Jeffrey Bly
    Louis Brause
    Michelle Chrein
    Steven B. Cohen
    Bonnie E. Fish
    Paul T. Fox
    Donald Friedman♦
    Tamir Gilat
    Kenneth E. Goodman
    Gary I. Grad, MD
    Robert Greene
    Maryanne Greenfield
    Samuel Herzfeld
    Clive Kabatznik
    Ian Kady
    Barbara Kasell
    Susan Matteson King
    Richard Lipkin
    Moni Lustig
    David Malkin, MD
    Patrick Mundt
    Linnea Olson
    Lisa Oved
    Tom Peled
    Jane Rabhan
    Sarah Rosen
    Lisa Schoenberg
    Sidney J. Winawer, MD♦
    Dov Zevy

  • Presidents Emeritus

    Harriet Elisofon
    Brad Goldhar
    Yashar Hirshaut, MD
    Harvey Kaylie*
    Daniel G. Miller, MD*
    Theodore T. Miller, MD

  • Chairpersons Emeritus

    Donald Friedman♦
    Kenneth E. Goodman
    Yashar Hirshaut, MD
    Michael Rosenfelt
    Leah Susskind*
    Eve Wald

  • Honorary Board Members

    Evelyn Bienenfeld
    Benjamin Brafman
    Lynda Brafman
    Harriet Elisofon
    Maralyn Friedman
    Faith G. Miller
    Steven T. Rosen, MD
    Michael Rosenfelt
    Judith Sherman
    Michel Steinberger
    Eve Wald

  • National Executive Director

    Mark A. Israel, MD

  • * Deceased
    ♦ Charter Board Member

    Help End the Suffering Caused By Cancer

    Support groundbreaking cancer research in Israel today: